Morphosys Ag (MOR) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MorphoSys AG has announced a merger squeeze-out with Novartis BidCo Germany AG offering a cash compensation of EUR 68.00 per share for the transfer of shares from minority shareholders. This action is pending approval at the MorphoSys AG Annual General Meeting and subsequent registrations in commercial registers. The court-appointed expert auditor has preliminarily affirmed the fairness of the compensation amount.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.

